[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
August 1960

Use of 5-Fluorouracil in the Management of Advanced Malignancies in Childhood

Author Affiliations

Department of Pediatrics, University of Minnesota Medical School (14).; Assistant Professor (Dr. Krivit) and Research Fellow (Dr. Bentley), Department of Pediatrics, University of Minnesota.

Am J Dis Child. 1960;100(2):217-227. doi:10.1001/archpedi.1960.04020040219010

Heidelberger, Pleven, and Duschinsky and associates in 1957 specifically designed 5-fluorouracil as an antimetabolite for cancer chemotherapy.1,2 Beneficial effects of 5-fluorouracil on experimental animal cancers were obtained.3 Subsequent clinical trials have indicated the efficacy of 5-fluorouracil (5-FU) in treatment of hepatoma, cancer of colon, rectum, and breast.

Murphy6 and Wolman7 have reported the use of 5-fluoro2#x2032;-deoxyuridine in the treatment of leukemia and neoplasms of childhood. Ansfield8 has noted that the 5-FU compounds produce less toxicity in children than in adults.

This clinical study is a report of 16 children who have received 5-FU for advanced or disseminated malignancies. The disappearance and reduction in size of malignancies following 5-FU have been remarkable. Complete regression of tumor has been noted in one patient with sarcoma of the larynx and in one patient with lymphosarcoma of the abdomen.

Methods and Materials  All the patients treated in this series had the diagnosis

Duschinsky, R.; Pleven, E., and Heidelberger, C.:  Synthesis of 5-Fluoropyrimidines , J. Am. Chem. Soc. 79:4559-4560, 1957.Article
Heidelberger, C.; Chaudhuri, N. K.; Danneberg, P.; Mooren, D.; Greisbach, L.; Duschinsky, R.; Schnitzer, R. J.; Pleven, E., and Scheiner, J.:  Fluorinated Pyrimidines, a New Class of Tumor-Inhibitory Compounds , Nature 179:663-666 ( (March 30) ) 1957.Article
Heidelberger, C.; Greisbach, L.; Montag, B. J.; Mooren, D.; Cruz, O.; Schnitzer, R. J., and Grunberg, E.:  Studies on Fluorinated Pyrimidines: II. Effects on Transplanted Tumors , Cancer. Res. 18:305-317 (April) 1958.
Curreri, A. R.; Ansfield, F. J.; McIver, F. A.; Waisman, H. A., and Heidelberger, C.:  Clinical Studies with 5-Fluorouracil , Cancer Res. 18:478-484 ( (May) ) 1958.
Ansfield, F. J., and Curreri, A. R.:  Further Clinical Studies with 5-Fluorouracil , J. Nat. Cancer Inst. 22:497-507 ( (March) ) 1959.
Murphy, M. L.; Ellison, R. R.; Aguila, F. S.; Sullivan, R.; Li, M. C., and Burchenal, J. H.:  Preliminary Clinical Studies with 5-Fluoro-2′-Deoxyuridine (5-FUDR) in Acute Leukemia , Cancer Chemotherap. Rep. 2:12-13 ( (March) ) 1959.
Wolman, I. J., and Gens, R. D.:  Progress Report on the Use of 5-Fluoro-2′-Deoxyuridine (5-FUDR) in Childhood Leukemias and Neoplasia , Cancer Chemotherap. Rep. 2:14-15 ( (March) ) 1959.
Ansfield, F. J.:  Toxicity and Preliminary Clinical Studies with 5-Fluoro-2′-Deoxyuridine (5-FUDR), abstracted , Proc. Am. A. Cancer Res. 3:3, 1959.
Creech, O., Jr.; Krementz, E. T.; Ryan, R. F.; Reemtsma, K., and Winblad, J. N.:  Experiences with Isolation-Perfusion Technics in the Treatment of Cancer , Ann. Surg. 149:627-640 ( (May) ) 1959.Article
Chaudhuri, N. K.; Montag, B. J., and Heidelberger, C.:  Studies on Fluorinated Pyrimidines: III. The Metabolism of 5-Fluorouracil-2-C14 and 5-Fluoroorotic-2-C14 Acid in Vivo , Cancer Res. 18:318-328 ( (April) ) 1958.
Danneberg, P. B.; Montag, B. J., and Heidelberger, C.:  Studies on Fluorinated Pyrimidines: IV. Effects on Nucleic Acid Metabolism in Vivo , Cancer Res. 18:329-334 ( (April) ) 1958.
Bosch, L.; Harbers, E., and Heidelberger, C.:  Studies on Fluorinated Pyrimidines: V. Effects on Nucleic Acid Metabolism in Vitro , Cancer Res. 18:335-343 ( (April) ) 1958.
Lindner, A.:  Cytochemical Effects of 5-Fluorouracil on Sensitive and Resistant Ehrlich Ascites Tumor Cells , Cancer Res. 19:189-194 ( (Feb.) ) 1959.
Rich, M. A.; Bolaffi, J. L.; Knoll, J. E.; Cheong, L., and Eidenoff, M. L.:  Growth Inhibition of a Human Tumor Cell Strain by 5-Fluorouracil, 5-Fluorouridine, and 5-Fluoro-2′-Deoxyuridine: Reversal Studies , Cancer Res. 18: 730-735 ( (June) ) 1958.
Brennan, M. J., and Vaitkevicius, V. K.:  5-Fluorouracil Alone and with 6-Mercaptopurine in the Clinical Therapy of Solid Tumors, abstracted , Proc. Am. A. Cancer Res. 3:9, 1959.
Burchenal, J. H.; Holmberg, E. A.; Fox, J. J.; Hemphill, S. C., and Reppert, J. A.:  The Effects of 5-Fluorodeoxycytidine, 5-Fluorodeoxyuridine, and Related Compounds on Transplanted Mouse Leukemias , Cancer Res. 19:494-500 ( (June) ) 1959.